株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

スルファジアジン銀の世界市場:用途 (創傷ケア、火傷ケア、スキンケア、尿路感染症)・地域別の将来予測

Silver Sulfadiazine Market: By Application (Wound Care, Burn Care, Skin Care, UTIs) & By Geography (Europe, Asia Pacific, North America, Rest of the World)-Forecast 2019-2024

発行 IndustryARC 商品コード 422493
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.93円で換算しております。
Back to Top
スルファジアジン銀の世界市場:用途 (創傷ケア、火傷ケア、スキンケア、尿路感染症)・地域別の将来予測 Silver Sulfadiazine Market: By Application (Wound Care, Burn Care, Skin Care, UTIs) & By Geography (Europe, Asia Pacific, North America, Rest of the World)-Forecast 2019-2024
出版日: 2018年12月06日 ページ情報: 英文
概要

当レポートでは、世界のスルファジアジン銀の市場について分析し、製品の概要や全体的な市場構造、主な市場促進・抑制要因、用途別・地域別の市場動向見通し (今後7年間分)、市場競争の概況、昨今の資本取引・戦略展開の動き、主要企業のプロファイルなどについて調査しております。

第1章 スルファジアジン銀:市場概要

第2章 エグゼクティブ・サマリー

第3章 市場環境

  • 市場シェア分析
  • 比較分析
  • 製品の相互比較
  • エンドユーザーのプロファイリング
  • 上位5社の財務分析

第4章 スルファジアジン銀市場:影響要因

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 課題
  • ポーターのファイブフォース分析

第5章 スルファジアジン銀市場:戦略分析

  • バリューチェーン分析
  • 価格動向分析
  • 市場機会の分析
  • 製品/市場ライフサイクル分析
  • サプライヤー・流通業者

第6章 スルファジアジン銀市場:用途別

  • 創傷ケア
  • 火傷ケア
  • スキンケア
  • 尿路感染症 (UTI)
  • パーソナルケア
  • その他

第7章 スルファジアジン銀市場:地域別

  • 欧州 (ドイツ、フランス、イタリア、スペイン、ロシア、英国など)
  • アジア太平洋地域 (中国、インド、日本、韓国など)
  • 北米 (米国、カナダ、メキシコ)
  • 他の国々 (RoW:ブラジルなど)

第8章 スルファジアジン銀:市場変化の方向性

  • 事業拡張
  • 技術開発
  • 企業合併・買収 (M&A)、合弁事業
  • 供給契約

第9章 企業プロファイル

第11章 付録

目次

Silver sulfadiazine is an antibacterial drug used for making personal care products. Silver sulfadiazine is listed as the essential medicines by World Health Organization and is widely used as an antibiotic for treating second and third degree burn wounds on the skin. Silver sulfadiazine also helps in preventing the growth of bacteria and yeast on the skin. Silver sulfadiazine is also commonly used to treat urinary tract infections (UTIs). Sulfadiazine, when combined with pyrimethamine, is used for curing the disease Toxoplasmosis. The healing capacity of silver sulfadiazine has been questioned over and again by various researchers and numerous research studies. Despite varied market opinions; silver sulfadiazine remains to be one of the most popular medicines for treatment on burns as it's is considered to be a powerful medication for burn wounds. Additionally, silver sulfadiazine is used in majority of the hospitals in North America as it is considered the most powerful treatment for burns. Globally increasing incidences of the burn injuries and increasing adoption in developing nations is expected drive the global demand for Silver sulfadiazine during the period of study.

Geographically North America dominated silver sulfadiazine market driven by best in the class healthcare infrastructure, advanced facilities, higher awareness, higher technological penetration and higher spending by the citizens towards healthcare expenditure. North America was followed by Europe and Asia-Pacific as second and third largest market for silver sulfadiazine market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing healthcare infrastructure, increased spending, government initiatives and increasing awareness amongst population, and growing medical tourism industry in developing nations such as China, and India in this region.

This report identifies the global silver sulfadiazine market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global silver sulfadiazine market.

This report segments global silver sulfadiazine market on the basis of application and regional market as follows:

Silver Sulfadiazine Market research report is classified on the basis of application. Some of the major applications of silver sulfadiazine covered in this report are as follows: Wound Care, Burn Care, Skin Care, Urinary Tract Infections (UTIs)

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the silver sulfadiazine market. Some of the major companies' profiles in detail are as follows:

Johnson & Johnson Limited

3M Company

Baxter International Inc

Monarch Pharmaceuticals

Teva Pharmaceutical Industries Ltd.

Table of Contents

1. Silver Sulfadiazine Market - Market Overview

2. Executive Summary

3. Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Silver Sulfadiazine Market- Market Forces

  • 4.1. Drivers
    • 4.1.1. Growing cases of burn injuries
  • 4.2. Restraints
    • 4.2.1. Volatile Silver Prices , a major raw material
  • 4.3. Opportunities
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Silver Sulfadiazine Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Silver Sulfadiazine Market, By Application

  • 6.1. Wound Care
  • 6.2. Burn Care
  • 6.3. Skin Care
  • 6.4. Urinary Tract Infections (UTIs)
  • 6.5. Personal Care
  • 6.6. Others

7. Silver Sulfadiazine Market, By Geography

  • 7.1. Europe
    • 7.1.1. Germany
    • 7.1.2. France
    • 7.1.3. Italy
    • 7.1.4. Spain
    • 7.1.5. Russia
    • 7.1.6. U.K.
    • 7.1.7. Rest of Europe
  • 7.2. Asia Pacific
    • 7.2.1. China
    • 7.2.2. India
    • 7.2.3. Japan
    • 7.2.4. South Korea
    • 7.2.5. Rest of Asia-Pacific
  • 7.3. North America
    • 7.3.1. U.S.
    • 7.3.2. Canada
    • 7.3.3. Mexico
  • 7.4. Rest of the World (RoW)
    • 7.4.1. Brazil
    • 7.4.2. Rest of RoW

8. Silver Sulfadiazine Market - Market Entropy

  • 8.1. Expansion
  • 8.2. Technological Developments
  • 8.3. Merger & Acquisitions, and Joint Ventures
  • 8.4. Supply- Contract

9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 9.1. Johnson & Johnson Limited
  • 9.2. 3M Company
  • 9.3. Baxter International Inc
  • 9.4. Monarch Pharmaceuticals
  • 9.5. Teva Pharmaceutical Industries Ltd.
  • 9.6. Pfizer Inc
  • 9.7. BASF SE
  • 9.8. LEK Pharmaceuticals DD
  • 9.9. Mallinckrodt Inc.
  • 9.10. NAPP Chemicals Inc.

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

10. Appendix

  • 10.1. Abbreviations
  • 10.2. Sources
  • 10.3. Research Methodology
  • 10.4. Bibliography
  • 10.5. Compilation of Expert Insights
  • 10.6. Disclaimer
Back to Top